1. Home
  2. ASNS vs MYNZ Comparison

ASNS vs MYNZ Comparison

Compare ASNS & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASNS
  • MYNZ
  • Stock Information
  • Founded
  • ASNS 1998
  • MYNZ 2021
  • Country
  • ASNS United States
  • MYNZ Germany
  • Employees
  • ASNS N/A
  • MYNZ N/A
  • Industry
  • ASNS Telecommunications Equipment
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASNS Telecommunications
  • MYNZ Health Care
  • Exchange
  • ASNS Nasdaq
  • MYNZ Nasdaq
  • Market Cap
  • ASNS 6.7M
  • MYNZ 7.9M
  • IPO Year
  • ASNS 2022
  • MYNZ 2021
  • Fundamental
  • Price
  • ASNS $0.51
  • MYNZ $1.77
  • Analyst Decision
  • ASNS Strong Buy
  • MYNZ Buy
  • Analyst Count
  • ASNS 1
  • MYNZ 2
  • Target Price
  • ASNS $5.00
  • MYNZ $14.00
  • AVG Volume (30 Days)
  • ASNS 513.0K
  • MYNZ 180.5K
  • Earning Date
  • ASNS 08-14-2025
  • MYNZ 08-26-2025
  • Dividend Yield
  • ASNS N/A
  • MYNZ N/A
  • EPS Growth
  • ASNS N/A
  • MYNZ N/A
  • EPS
  • ASNS N/A
  • MYNZ N/A
  • Revenue
  • ASNS $5,265,000.00
  • MYNZ $893,991.00
  • Revenue This Year
  • ASNS N/A
  • MYNZ $26.06
  • Revenue Next Year
  • ASNS $104.77
  • MYNZ $4.97
  • P/E Ratio
  • ASNS N/A
  • MYNZ N/A
  • Revenue Growth
  • ASNS N/A
  • MYNZ N/A
  • 52 Week Low
  • ASNS $0.45
  • MYNZ $1.30
  • 52 Week High
  • ASNS $1.86
  • MYNZ $18.40
  • Technical
  • Relative Strength Index (RSI)
  • ASNS 39.85
  • MYNZ 53.56
  • Support Level
  • ASNS $0.57
  • MYNZ $1.41
  • Resistance Level
  • ASNS $0.64
  • MYNZ $1.76
  • Average True Range (ATR)
  • ASNS 0.06
  • MYNZ 0.16
  • MACD
  • ASNS 0.01
  • MYNZ 0.02
  • Stochastic Oscillator
  • ASNS 26.24
  • MYNZ 68.12

About ASNS Actelis Networks Inc.

Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The company operates as one operating segment: developing and marketing access broadband equipment for copper and fiber networks.

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Share on Social Networks: